Stay updated on Sotorasib in KRAS-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS-Mutant Solid Tumors Clinical Trial page.

Latest updates to the Sotorasib in KRAS-Mutant Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added indicating February 7, 2025. However, the removal of the date March 25, 2025, does not significantly impact core content.SummaryDifference1.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a contact email for assistance. Additionally, a date has been added, indicating February 7, 2025.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Sotorasib in KRAS-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS-Mutant Solid Tumors Clinical Trial page.